奥普生物 (873758.oc)

+ 收藏

利润表(奥普生物)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2023年年报2023年中报2022年年报2022年中报
上市前/上市后 上市后上市后上市后上市前
报表类型 合并报表合并报表合并报表合并报表
一、营业总收入(元) 185,175,746.9979,043,786.94135,668,553.7566,104,216.93
 营业收入(元) 185,175,746.9979,043,786.94135,668,553.7566,104,216.93
二、营业总成本(元) 162,589,683.1570,245,678.87124,919,490.5156,278,274.99
 营业成本(元) 66,228,024.6625,535,459.2638,638,055.8716,527,324.91
 研发费用(元) 30,396,438.2914,600,268.6630,940,446.8214,816,434.19
 营业税金及附加(元) 1,655,477.43772,725.401,379,365.08752,809.90
 销售费用(元) 44,005,969.8721,964,458.3938,553,319.0717,979,989.10
 管理费用(元) 23,648,570.8210,024,668.1419,680,444.848,259,153.34
 财务费用(元) -3,344,797.92-2,651,900.98-4,272,141.17-2,057,436.45
  其中:利息费用(元) 68,326.86-65,340.86-
  其中:利息收入(元) 2,715,526.00-1,295,452.271,749,043.65-707,767.95
三、其他经营收益
 加:公允价值变动收益(元) 397,618.228,492.5886,394.32-
 加:投资收益(元) 310,027.17225,385.5838,010.9673,687.12
 资产处置收益(元) -260,501.2568,362.88-49,464.68-71,596.50
 资产减值损失(元) -847,865.35-453,730.994.65
 信用减值损失(元) -884,530.51290,341.00-846,240.14-
 其他收益(元) 4,543,320.60592,847.778,334,880.382,351,393.86
四、营业利润(元) 25,844,132.729,983,537.8818,766,375.0712,179,431.07
 加:营业外收入(元) 15,512.209,758.86114,876.780.17
 减:营业外支出(元) 408,966.26474,657.90172,147.84250.00
五、利润总额(元) 25,450,678.669,518,638.8418,709,104.0112,179,181.24
 减:所得税费用(元) 333,428.95985,338.281,477,564.161,886,912.24
六、净利润(元) 25,117,249.718,533,300.5617,231,539.8510,292,269.00
(一)按经营持续性分类
  持续经营净利润(元) 25,117,249.718,533,300.5617,231,539.8510,292,269.00
(二)按所有权归属分类
  归属于母公司股东的净利润(元) 23,965,866.197,576,163.8717,272,794.9610,433,664.08
  少数股东损益(元) 1,151,383.52957,136.69-41,255.11-141,395.08
 扣除非经常性损益后的净利润(元) 19,963,020.437,120,644.239,756,748.96-
七、每股收益
 一、基本每股收益(元) 0.400.130.300.19
 二、稀释每股收益(元) 0.400.130.300.19
九、综合收益总额(元) 25,117,249.718,533,300.5617,231,539.8510,292,269.00
 归属于母公司所有者的综合收益总额(元) 23,965,866.197,576,163.8717,272,794.9610,433,664.08
 归属于少数股东的综合收益总额(元) 1,151,383.52957,136.69-41,255.11-141,395.08
公告日期 2024-04-252023-08-182023-04-182023-08-18
审计意见(境内) 标准无保留意见标准无保留意见
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院